NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 184 filers reported holding NPS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,073,000 | +65.1% | 30,000 | +20.0% | 0.58% | +25.9% |
| Q3 2014 | $650,000 | -43.8% | 25,000 | -28.6% | 0.46% | -36.2% |
| Q2 2014 | $1,157,000 | -22.7% | 35,000 | -30.0% | 0.72% | -11.0% |
| Q1 2014 | $1,497,000 | -17.8% | 50,000 | -16.7% | 0.81% | -8.2% |
| Q4 2013 | $1,822,000 | -11.9% | 60,000 | -7.7% | 0.88% | -30.3% |
| Q3 2013 | $2,068,000 | +125.3% | 65,000 | +7.0% | 1.26% | +93.6% |
| Q2 2013 | $918,000 | – | 60,750 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 431,475 | $15,433,000 | 5.92% |
| SECTORAL ASSET MANAGEMENT INC | 1,623,073 | $58,057,000 | 2.60% |
| Palo Alto Investors LP | 1,190,263 | $42,576,000 | 2.50% |
| Fiera Capital (Europe) Ltd. | 426,250 | $3,246,000 | 2.39% |
| BENDER ROBERT & ASSOCIATES | 75,080 | $2,686,000 | 1.76% |
| FCG ADVISORS, LLC | 76,865 | $3,138,000 | 1.55% |
| Penn Capital Management Company, LLC | 857,621 | $30,677,000 | 1.29% |
| NEXT CENTURY GROWTH INVESTORS LLC | 927,285 | $33,168,000 | 1.20% |
| Tekla Capital Management LLC | 625,900 | $22,388,000 | 1.05% |
| Orbimed Advisors | 2,954,900 | $105,697,000 | 1.01% |